Rockwell Medical, Inc. (NASDAQ: RMTI) Starts Presentation at the 2017 Disruptive Growth Company Showcase

Rockwell Medical (NASDAQ: RMTI) is a fully-integrated biopharmaceutical company with a focus on end-stage renal disease (ESRD) and chronic kidney disease (CKD). The company provides innovative products for the treatment of iron replacement, secondary hyperparathyroidism and hemodialysis. Triferic, the company’s anemia drug, is FDA approved for iron replacement and maintenance of hemoglobin in hemodialysis patients. The company also has an FDA approved generic drug, Calcitriol, for treating secondary hyperparathyroidism in dialysis patients. Rockwell also manufactures high-quality hemodialysis concentrates/dialysates to dialysis providers and distributors in the U.S. and abroad. For more information, visit the company’s website at www.rockwellmed.com.

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Archives

Select A Month

Contact us: 212.418.1217